MedPath

Are gut hormone changes the reason why the long-limb gastric bypass is more effective than the standard limb gastric bypass in improving type 2 diabetes mellitus?

Not Applicable
Completed
Conditions
Topic: Diabetes
Subtopic: Type 2
Nutritional, Metabolic, Endocrine
Disease: Diabetic Control, Obesity
Registration Number
ISRCTN15283219
Lead Sponsor
Imperial College London
Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33158945/ (added 23/09/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33617177/ (added 18/08/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
53
Inclusion Criteria

1. Both genders
2. Age 18-70 years
3. Type 2 diabetes mellitus
4. Obesity
5. HbA1c>7.0%
6. On glucose-lowering medication

Exclusion Criteria

1. Contraindications to bariatric surgery
2. Type 1 diabetes
3. Pregnancy or breastfeeding
4. Recent blood donation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath